Back
iBio 10K Form
Sell
40
IBIO
iBio
Last Price:
2.69
Seasonality Move:
-14.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IBIO News And Ratings
See the #1 stock for the next 7 days that we like better than IBIO
IBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $225K |
|---|---|
| Cash Flow: | $-4.85M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.47 |
| Price / Book: | 1.08 |
Profitability
| EPS (TTM): | -10.97190 |
|---|---|
| Net Income (TTM): | $-24.91M |
| Gross Margin: | $2.17M |
| Return on Equity: | -148.3% |
| Return on Assets: | -64.93% |
iBio Earnings Forecast
Key iBio Financial Ratios
- The Gross Profit Margin over the past 16 years for IBIO is 115.18%.
- The Selling, General & Administrative Expenses for IBIO have been equal to 5,188.44% of Gross Profit Margin.
- The Research & Development expenses have been 2,304.44% of Revenue.
- The Interest Expense is -0.69% of Operating Income.
- The Net Earning history of IBIO is -11,069.78% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 9 years.
iBio Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IBIO |
| CUSIP: | 451033 |
| Website: | ibioinc.com |
Debt
| Debt-to-Equity Ratio: | 0.05 |
|---|---|
| Current Ratio: | 4.08 |
| Quick Ratio: | 3.89 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |